A recent study found that co-treatment with MLA promoted the reduction of BDNF in the hippocampus and worsened Aβ-induced cognitive impairment, suggesting a determinant role of α7nAChR in BDNF expression and memory recovery in AD (Telles-Longui et al., 2019). This evidence concerns the gene CHRNA7 and Alzheimer disease.